BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20521637)

  • 1. Immunogenicity of poxvirus vector avian influenza vaccines in Muscovy and Pekin ducks.
    Bublot M; Richard-Mazet A; Chanavat-Bizzini S; Le Gros FX; Duboeuf M; Stoll A; Palfi V; Niqueux E; Guionie O; Dren N
    Avian Dis; 2010 Mar; 54(1 Suppl):232-8. PubMed ID: 20521637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
    Niqueux E; Guionie O; Amelot M; Jestin V
    Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.
    Steensels M; Bublot M; Van Borm S; De Vriese J; Lambrecht B; Richard-Mazet A; Chanavat-Bizzini S; Duboeuf M; Le Gros FX; van den Berg T
    Vaccine; 2009 Jan; 27(5):646-54. PubMed ID: 19056442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge.
    Steensels M; Van Borm S; Lambrecht B; De Vriese J; Le Gros FX; Bublot M; van den Berg T
    Avian Dis; 2007 Mar; 51(1 Suppl):325-31. PubMed ID: 17494576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies.
    Richard-Mazet A; Goutebroze S; Le Gros FX; Swayne DE; Bublot M
    Vet Res; 2014 Oct; 45(1):107. PubMed ID: 25359591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine.
    Cagle C; To TL; Nguyen T; Wasilenko J; Adams SC; Cardona CJ; Spackman E; Suarez DL; Pantin-Jackwood MJ
    Vaccine; 2011 Sep; 29(38):6549-57. PubMed ID: 21771626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines.
    Le T; Le T; Doan TH; Quyen D; Le KX; Pham V; Nagataki M; Nomura H; Ikeue Y; Watanabe Y; Agatsuma T
    J Microbiol Biotechnol; 2011 Apr; 21(4):405-11. PubMed ID: 21532325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam.
    Pfeiffer J; Suarez DL; Sarmento L; To TL; Nguyen T; Pantin-Jackwood MJ
    Avian Dis; 2010 Mar; 54(1 Suppl):262-71. PubMed ID: 20521643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Turkey Herpesvirus-AI Vaccine Virus Replication in Different Species of Waterfowl.
    Palya V; Kovács EW; Tatár-Kis T; Felföldi B; Homonnay ZG; Mató T; Sato T; Gardin Y
    Avian Dis; 2016 May; 60(1 Suppl):210-7. PubMed ID: 27309057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune response of a recombinant fowlpox virus coexpressing the HA gene of the H5N1 highly pathogenic avian influenza virus and chicken interleukin 6 gene in ducks.
    Qian C; Chen S; Ding P; Chai M; Xu C; Gan J; Peng D; Liu X
    Vaccine; 2012 Sep; 30(44):6279-86. PubMed ID: 22902682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of protection induced by two fowlpox vector vaccines against a highly pathogenic avian influenza H5N1 challenge in specific-pathogen-free chickens.
    Bublot M; Manvell RJ; Shell W; Brown IH
    Avian Dis; 2010 Mar; 54(1 Suppl):257-61. PubMed ID: 20521642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
    Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
    Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in pathogenicity, response to vaccination, and innate immune responses in different types of ducks infected with a virulent H5N1 highly pathogenic avian influenza virus from Vietnam.
    Cagle C; Wasilenko J; Adams SC; Cardona CJ; To TL; Nguyen T; Spackman E; Suarez DL; Smith D; Shepherd E; Roth J; Pantin-Jackwood MJ
    Avian Dis; 2012 Sep; 56(3):479-87. PubMed ID: 23050463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.
    Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K
    Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.
    Swayne DE
    Ann N Y Acad Sci; 2006 Oct; 1081():174-81. PubMed ID: 17135509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.
    Isoda N; Sakoda Y; Kishida N; Soda K; Sakabe S; Sakamoto R; Imamura T; Sakaguchi M; Sasaki T; Kokumai N; Ohgitani T; Saijo K; Sawata A; Hagiwara J; Lin Z; Kida H
    Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the Newcastle disease virus H5 vaccine in ducks.
    Ferreira HL; Pirlot JF; Reynard F; van den Berg T; Bublot M; Lambrecht B
    Avian Dis; 2012 Dec; 56(4 Suppl):940-8. PubMed ID: 23402116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance.
    James CM; Foong YY; Mansfield JP; Vind AR; Fenwick SG; Ellis TM
    Vaccine; 2008 Oct; 26(42):5345-51. PubMed ID: 18723069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.
    Bublot M; Pritchard N; Cruz JS; Mickle TR; Selleck P; Swayne DE
    Avian Dis; 2007 Mar; 51(1 Suppl):498-500. PubMed ID: 17494618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.